Allograft Tolerance
Showing 1 - 25 of 5,888
Renal Failure Trial in Boston (Rituximab, Fludarabine, Cyclophosphamide, Thymic irradiation and Siplizumab, Combined bone marrow
Recruiting
- Renal Failure
- Rituximab, Fludarabine, Cyclophosphamide, Thymic irradiation and Siplizumab
- Combined bone marrow and kidney transplant
-
Boston, MassachusettsMassachusetts General Hospital
Jan 19, 2023
Kidney Failure, Chronic, Renal Insufficiency Trial in Boston (drug, radiation, procedure)
Completed
- Kidney Failure, Chronic
- Renal Insufficiency
- Belatacept
- +5 more
-
Boston, MassachusettsMassachusetts General Hospital
Oct 4, 2021
End Stage Renal Disease Trial in Boston (MEDI-507, Rituximab, Total Body Irradiation)
Completed
- End Stage Renal Disease
- MEDI-507
- +3 more
-
Boston, MassachusettsMassachusetts General Hospital
Mar 19, 2021
Kidney Transplantation Trial (High throughput DNA and RNA sequencing)
Completed
- Kidney Transplantation
- High throughput DNA and RNA sequencing
- (no location specified)
Nov 10, 2021
A Cohort Study of Operationally Tolerant Allograft Recipients
Terminated
- Kidney Transplant
- Liver Transplant
- Blood Draw
-
San Francisco, California
- +4 more
Aug 25, 2021
Kidney Failure, Kidney Transplant; Complications, Chimera Trial (other, procedure, drug)
Not yet recruiting
- Kidney Failure
- +2 more
- Bone Marrow Transplant
- +2 more
- (no location specified)
Jun 9, 2023
Enucleated; Eye, Eye Cancer Trial in Paris (SclerFIX)
Recruiting
- Enucleated; Eye
- Eye Cancer
- SclerFIX
-
Paris, FranceInstitut Curie
Oct 20, 2022
Scleral Thinning Trial in Nice (SclerFIX)
Recruiting
- Scleral Thinning
- SclerFIX
-
Nice, FranceHôpital Pasteur 2 - CHU de NICE
Aug 4, 2022
Kidney Transplantation Trial in Baltimore, Livingston, New York (TCD601)
Recruiting
- Kidney Transplantation
- TCD601
-
San Francisco, California
- +4 more
Oct 28, 2022
Kidney Transplantation Trial in United States (TCD601)
Not yet recruiting
- Kidney Transplantation
- TCD601
-
Chicago, Illinois
- +4 more
Jun 13, 2022
Organ Transplantation Trial in Atlanta (Belatacept, Sirolimus, Alemtuzumab)
End Stage Kidney Disease, Immunological Tolerance, Kidney Transplant Failure and Rejection Trial in Los Angeles (Donor CD34+,
Not yet recruiting
- End Stage Kidney Disease
- +3 more
- Donor CD34+, CD3+. and belumosudil
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Apr 6, 2023
Kidney Failure Trial in Chicago, Durham (Enriched Hematopoietic Stem Cell Infusion)
Active, not recruiting
- Kidney Failure
- Enriched Hematopoietic Stem Cell Infusion
-
Chicago, Illinois
- +1 more
Jul 15, 2022
Liver Transplant, Liver Transplantation Trial in United States (Immunosuppression withdrawal)
Completed
- Liver Transplant
- Liver Transplantation
- Immunosuppression withdrawal
-
San Francisco, California
- +6 more
Aug 10, 2022
Renal Failure Trial in Chicago, Louisville (Enriched Hematopoietic Stem Cell Infusion)
Active, not recruiting
- Renal Failure
- Enriched Hematopoietic Stem Cell Infusion
-
Chicago, Illinois
- +1 more
Jul 15, 2022
Kidney; Complications, Allograft, Transplantation Infection Trial in Loma Linda (Immunosuppressive Agents)
Active, not recruiting
- Kidney; Complications, Allograft
- Transplantation Infection
- Immunosuppressive Agents
-
Loma Linda, CaliforniaLoma Linda University Medical Center, Transplantation Institute
Apr 28, 2022
Living Donor Liver Transplantation Trial in Pittsburgh (Donor-derived DCreg)
Active, not recruiting
- Living Donor Liver Transplantation
- Donor-derived DCreg
-
Pittsburgh, PennsylvaniaUPMC
Sep 7, 2022
End Stage Renal Disease Trial in Zurich (Kidney and hematopoietic stem cell transplantation, hematopoietic stem cell)
Recruiting
- End Stage Renal Disease
- Kidney and hematopoietic stem cell transplantation
- hematopoietic stem cell
-
Zurich, SwitzerlandUniversity Hospital Zurich
Mar 31, 2022
piTie-Salpetriere University Hospital
Completed
- Cardiac Transplant Disorder
- +7 more
- (no location specified)
Sep 24, 2019
Multiple Myeloma, Amyloidosis Trial in Boston (drug, procedure, radiation)
Completed
- Multiple Myeloma
- Amyloidosis
- Tacrolimus
- +4 more
-
Boston, MassachusettsMassachusetts General Hospital
Aug 24, 2021
De Novo Autoimmune Hepatitis in Pediatric Liver Transplantation
Terminated
- De Novo Autoimmune Hepatitis
- Pediatric transplant subject with d-AIH
- +6 more
- (no location specified)
Dec 9, 2021
Liver Transplant Trial in Boston (biological, procedure, drug)
Recruiting
- Liver Transplant
- arTreg-CSB
- +4 more
-
Boston, MassachusettsMassachusetts General Hospital: Transplantation
Jan 30, 2023
Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute
Recruiting
- Acute Rejection of Renal Transplant
- Graft Failure
- Donor-derived cell-free DNA
-
Loma Linda, CaliforniaLoma Linda University Health
Jul 19, 2022
Transplantation, Liver Trial in London, Newcastle (Biomarker, Tacrolimus, cyclosporine and/or mycophenolic acid, mycophenolate
Active, not recruiting
- Transplantation, Liver
- Biomarker
- Tacrolimus, cyclosporine and/or mycophenolic acid, mycophenolate mofetil or azathioprine
-
London, United Kingdom
- +1 more
Mar 10, 2021